Sitacure-M 50/500: Understanding Sitagliptin and Metformin Combination Therapy Managing type 2 diabetes often involves a combination of lifestyle changes and medicines that work in different ways to help maintain healthy blood glucose levels. Sitacure-M 50/500 combines two active ingredients, sitagliptin and metformin hydrochloride, which have complementary effects on blood sugar regulation. This combination may be prescribed when treatment with one medicine alone does not provide adequate glycaemic control, based on the healthcare professional’s assessment. Sitagliptin belongs to a group of medicines known as DPP-4 inhibitors, while metformin is a commonly used medicine for managing type 2 diabetes. Together, they can support blood glucose management through different mechanisms. Sitacure-M 50/500 should be taken only as directed by a qualified healthcare professional and used alongside an appropriate diet, regular physical activity and recommended blood glucose monitoring. Visit us : https://hertzpharma.com/sitacure-m-50-500.php